John Pasi

15.5k total citations · 5 hit papers
161 papers, 6.8k citations indexed

About

John Pasi is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, John Pasi has authored 161 papers receiving a total of 6.8k indexed citations (citations by other indexed papers that have themselves been cited), including 132 papers in Hematology, 22 papers in Molecular Biology and 22 papers in Genetics. Recurrent topics in John Pasi's work include Hemophilia Treatment and Research (111 papers), Platelet Disorders and Treatments (46 papers) and Blood Coagulation and Thrombosis Mechanisms (44 papers). John Pasi is often cited by papers focused on Hemophilia Treatment and Research (111 papers), Platelet Disorders and Treatments (46 papers) and Blood Coagulation and Thrombosis Mechanisms (44 papers). John Pasi collaborates with scholars based in United Kingdom, United States and South Africa. John Pasi's co-authors include Paula Bolton‐Maggs, Simon Noble, Savita Rangarajan, Glenn F. Pierce, Michael Laffan, Daniel P. Hart, Sean Platton, F. G. H. Hill, Will Lester and Wing Yen Wong and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Nature Medicine.

In The Last Decade

John Pasi

157 papers receiving 6.5k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Haemophilias A and B

2003 551 citations John Pasi et al. profile →
AAV5–Factor VIII Gene Transfer in Severe Hemophilia A

2017 515 citations Savita Rangarajan, Will Lester et al. profile →
Functional definition and characterization of acute traumatic coagulopathy

2011 380 citations Sean Platton, Daniel P. Hart et al. profile →
The incidence and magnitude of fibrinolytic activation in trauma patients

2012 344 citations Sean Platton, Daniel P. Hart et al. profile →
Multiyear Follow-up of AAV5-hFVIII-SQ Gene Therapy for Hemophilia A

2020 327 citations John Pasi, Savita Rangarajan et al. profile →

Peers

Countries citing papers authored by John Pasi

Since Specialization

Citations

This map shows the geographic impact of John Pasi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Pasi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Pasi more than expected).

Fields of papers citing papers by John Pasi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Pasi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Pasi. The network helps show where John Pasi may publish in the future.

Co-authorship network of co-authors of John Pasi

This figure shows the co-authorship network connecting the top 25 collaborators of John Pasi. A scholar is included among the top collaborators of John Pasi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Pasi. John Pasi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Post hoc longitudinal assessment of the efficacy and safety of recombinant factor IX Fc fusion protein in hemophilia B 2023 ·Blood Advances ·Amy D. Shapiro, Roshni Kulkarni, Margaret V. Ragni, Hérvè Chambost, Johnny Mahlangu, (unknown), Beatrice Nolan, Margareth C. Ozelo, Meredith C. Foster, Annemieke Willemze, (unknown), Nisha Jain, Bent Winding, Jennifer Dumont, Stefan Lethagen, Chris Barnes, John Pasi	4
2	Interindividual variability in transgene mRNA and protein production following adeno-associated virus gene therapy for hemophilia A 2022 ·Nature Medicine ·Sylvia Fong, Bridget Yates, Choong‐Ryoul Sihn, Aras N. Mattis, Nina Mitchell, Su Liu, Chris B. Russell, Benjamin Kim, (unknown), Savita Rangarajan, Will Lester, Stuart Bunting, Glenn F. Pierce, John Pasi, Wing Yen Wong	77
3	Managing surgery in hemophilia with recombinant factor VIII Fc and factor IX Fc: Data on safety and effectiveness from phase 3 pivotal studies 2022 ·Research and Practice in Thrombosis and Haemostasis ·Pratima Chowdary, Margareta Holmström, Johnny Mahlangu, (unknown), Ingrid Pabinger, John Pasi, Margaret V. Ragni, Amy D. Shapiro, (unknown), Stefan Lethagen	11
4	Long-Term Durability, Safety and Efficacy of Fitusiran Prophylaxis in People with Hemophilia a or B, with or without Inhibitors - Results from the Phase II Study 2020 ·Blood ·Steven W. Pipe, John Pasi, Toshko Lissitchkov, Margaret V. Ragni, Claude Négrier, Qifeng Yu, Stacey Poloskey, Baisong Mei, (unknown)	7
5	The impact of factor infusion frequency on health-related quality of life in people with haemophilia 2020 ·SHILAP Revista de lepidopterología ·Gabriel Pedra, P Christoffersen, Kate Khair, (unknown), (unknown), Jamie O’Hara, John Pasi	3
6	Towards a global multidisciplinary consensus framework on haemophilia gene therapy: Report of the 2nd World Federation of Haemophilia Gene Therapy Round Table 2020 ·Haemophilia ·Glenn F. Pierce, John Pasi, Donna Coffin, Radosław Kaczmarek, David Lillicrap, Johnny Mahlangu, (unknown), (unknown), Alok Srivastava, Thierry VandenDriessche, (unknown)	16
7	Perioperative Management in Patients with Hemophilia Receiving Fitusiran, an Investigational RNAi Therapeutic Targeting Antithrombin for the Treatment of Hemophilia 2017 ·Blood ·Claude Négrier, Margaret V. Ragni, Pencho Georgiev, Toshko Lissitchkov, Nguyễn Văn Huy, (unknown), John Pasi	9
8	Diagnostic accuracy study of a factor VIII ELISA for detection of factor VIII antibodies in congenital and acquired haemophilia A 2015 ·Thrombosis and Haemostasis ·Paul Batty, Gary Moore, Sean Platton, James P. Maloney, Ben Palmer, Louise Bowles, John Pasi, Savita Rangarajan, Daniel P. Hart	19
9	Evaluation of thromboelastography for monitoring recombinant activated factor VII ex vivo in haemophilia A and B patients with inhibitors: a multicentre trial 2008 ·Blood Coagulation & Fibrinolysis ·Guy Young, Liselotte S. Ebbesen, Dorthe Viuff, Jorge Di Paola, Barbara A. Konkle, Claude Négrier, John Pasi, Jørgen Ingerslev	52
10	Versatile Peptide Dendrimers for Nucleic Acid Delivery 2004 ·Journal of Pharmaceutical Sciences ·Henry K. Bayele, Thiagarajan Sakthivel, (unknown), John Pasi, Andrew F. Wilderspin, Christine A. Lee, István Tóth, Alexander T. Florence	45
11	Two novel mutations in severe factor VII deficiency 2004 ·British Journal of Haematology ·Keith Gomez, Michael Laffan, Geoffrey Kemball‐Cook, John Pasi, Mark Layton, J.D. Singer, Edward G. D. Tuddenham, John H. McVey	7
12	The effects of the 32-bp CCR-5 deletion on HIV transmission and HIV disease progression in individuals with haemophilia 2000 ·British Journal of Haematology ·John Pasi, Caroline Sabin, P. Vincent Jenkins, (unknown), (unknown), (unknown)	17
13	A survey of patients with acquired haemophilia in a haemophilia centre over a 28-year period 2000 ·Clinical & Laboratory Haematology ·T. T. Yee, Alì Taher, John Pasi, C. A. Lee	50
14	Recombinant factor VIIA is used in a Jehova's Witness with liver cirrhosis to correct prothrombin time, bleeding time, and thromboelastographic parameters, enabling safe percutaneous injection of hepatocellular carcinoma 1999 ·Thrombosis and Haemostasis ·George Papatheodoridis, S Chung, Satish Keshav, (unknown), John Pasi, A K Burroughs	1
15	Factor VIII inhibitors in haemophiliacs: a single‐centre experience over 34 years, 1964–97 1999 ·British Journal of Haematology ·T. T. Yee, John Pasi, (unknown), (unknown)	30
16	Thromboelastography: An effective screening test for prothrombotic states 1998 ·UCL Discovery (University College London) ·(unknown), (unknown), John Pasi, (unknown), (unknown)	7
17	Gene therapy for haemophilia: how far have we come? 1998 ·Haemophilia ·Paul Fields, John Pasi	2
18	Factor IX Inhibitors and Anaphylaxis in Hemophilia B 1997 ·The American journal of pediatric hematology/oncology ·Indira Warrier, Bruce M. Ewenstein, Marion A. Koerper, Amy D. Shapiro, Nigel S. Key, Donna DiMichele, Robert Miller, John Pasi, Georges E. Rivard, Steve S. Sommer, Jacob Katz, Frauke Bergmann, Rolf Ljung, Pia Petrini, Jeanne M. Lusher	128
19	Successful long‐term treatment with porcine factor VIII of a patient with haemophilia A and an inhibitor to factor VIII 1996 ·Haemophilia ·Paresh Vyas, John Pasi, (unknown)	6
20	Bleeding after tonsillectomy in severe von Willebrand's disease 1995 ·The Journal of Laryngology & Otology ·Ghassan Alusi, William E. Grant, C. A. Lee, John Pasi, Michael Stearns	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact